Paradigm Studios on MSN

Evil mother-in-law tried to break up the marriage

This is an acted sketch. An overbearing mother-in-law does everything she can to tear apart her son's marriage. Her actions ...
FIFA

Morocco hit spot to knock out Netherlands

Morocco booked their place in the FIFA World Cup 2026™ Round of 16 after edging past Netherlands in a highly-dramatic penalty shootout on an emotional night for Cody Gakpo at Monterrey Stadium. The ...

Takeda's Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Ex…

Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the Phase 3, randomized, multicenter, ...

In Oklahoma, poor families often have to live in the dark

TULSA - The lights went out when Tammy Dikes was in the shower. All of a sudden, her windowless bathroom went black. It was ...

The state that shuts off poor families’ power more often than anywhere else

Having your electricity disconnected is more common in Oklahoma than any other state.
News on 6

Coweta’s Planning Commission votes 4-1 to deny rezoning request for proposed data center

Coweta’s Planning Commission voted 4-1 deny a rezoning request to build a proposed data center on 270 acres of land between Highways 72 and 51-B, north of the Arkansas River. Before public comment ...
Yahoo

Takeda’s oral TYK2 blocker outperforms Sotyktu in PsO trial

Add Yahoo as a preferred source to see more of our stories on Google. Takeda is hoping to get a grasp on some of the PsA market which GlobalData forecasts will be worth $11.56bn in 2030. Credit: ...
Times Argus

Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly ...
Morningstar

Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Once-daily oral zasocitinib demonstrated statistical superiority over deucravacitinib for all primary and key secondary endpoints in plaque psoriasis study More than 35% of zasocitinib-treated ...
Tulsa World

Top of Atlas School building collapses amid windy weather

The top of the Atlas School building crumbled Wednesday afternoon, spilling bricks onto the sidewalk in front of the more than century-old building. Yellow caution tape flapped in the wind as ...